Everyday Health on MSN
GLP-1 diabetes drug Mounjaro gets FDA okay to reduce heart attack and stroke
Research shows this tirzepatide GLP-1/GIP medication may help prevent cardiovascular emergencies in high-risk type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results